The human brain works hard to control its environment. A specialized border called the blood-brain barrier protects the brain by blocking harmful substances in the bloodstream. But this blockade also keeps out medicines for treating addiction and other brain diseases. Understanding how the blood-brain barrier works brings us closer to delivering therapies to the brain.
What is the Blood-Brain Barrier?
The blood-brain barrier refers to the border between circulating blood and the central nervous system. Blood vessels in the brain are different from those in the rest of the body.
The border is formed by specialized cells that line the tiny brain blood vessels. These cells squeeze together tightly to form a continuous wall. This seals off the brain from toxins and germs.
The snug seal forces most molecules to take a special path between cells to cross the border. Only certain substances like oxygen and glucose sugar can pass through.
How Does the Blood-Brain Barrier Work?
The blood-brain barrier works as a filter by only allowing access to select molecules the brain needs. Adjacent border cells fit together extra tight to block stuff.
Useful molecules like glucose get actively transported across the cells through special carrier proteins. But the tight seal otherwise forces everything to take this difficult cellular path.
Lipid-soluble chemicals like alcohol can quickly slip through border cell membranes. But large or charged molecules generally can’t cross without a cellular transporter.
Why is the Blood-Brain Barrier So Important?
The blood-brain barrier is crucial for normal brain function. Blocking toxins and bacteria protects delicate neural signaling pathways in the brain.
Stopping random molecules from entering allows precise control over the brain’s environment. But it also blocks beneficial drugs from reaching the brain to treat diseases.
Disruption to the barrier has been linked to brain inflammation, seizures, and neurodegeneration. A healthy blood-brain barrier keeps the brain working properly.
How Does the Barrier Affect Addictive Drugs?
Addictive drugs are designed to circumvent the blood-brain barrier through cell membrane diffusion or transporter hijacking.
Long-term substance abuse can damage the barrier, increasing permeability. This allows more drugs to enter and likely worsens addiction.
Changes to the barrier also affect levels of neurotransmitters, hormones, and other chemicals in the brain important for function.
Can We Use the Barrier to Treat Addiction?
Understanding the biology of the blood-brain barrier suggests new approaches for treating addiction and mental illness.
Research into transport mechanisms offers possibilities for moving medications through the barrier and into specific brain regions.
Traversing the blood-brain barrier remains difficult, but steady progress provides hope. The intricate workings of this brain border may hold keys to revolutionary therapies.
The blood-brain barrier is the brain’s specialized security system, tightly controlling access to this precious organ. While crucial for brain health, it also blocks life-changing medications from entering. Now research into the intricate molecular biology of the barrier brings hope for drug delivery. As science maps the nuances of the brain’s gatekeeper, we move closer to regulated access for revolutionary therapies that target addiction, chronic pain, neurodegeneration and more. The future of medicine rests on harnessing the blood-brain barrier.
References
- Abbott, N. Joan, et al. “Structure and function of the blood–brain barrier.” Neurobiology of disease 37.1 (2010): 13-25. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826891/
- Pardridge, William M. “The blood-brain barrier: bottleneck in brain drug development.” NeuroRx 2.1 (2005): 3-14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539316/
- Hawkins, Brian T., and Juan R. Viña. “Fluid flow increases membrane fluidity of endothelial cells through phosphorylation of membrane proteins.” American Journal of Physiology-Heart and Circulatory Physiology 280.6 (2001): H2758-H2761. https://journals.physiology.org/doi/full/10.1152/ajpheart.2001.280.6.H2758
- Ronaldson, Patrick T., and Todd E. Persidsky. “Blood-brain barrier: structural components and function under physiological and pathological conditions.” Physiological reviews 98.3 (2018): 1751-1812. https://journals.physiology.org/doi/full/10.1152/physrev.00034.2017
- Miller, David S. “Regulation of ABC transporters at the blood-brain barrier.” Clinical Pharmacology & Therapeutics 97.4 (2015): 395-403. https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.42
- Qosa, Hisham, et al. “Regulation of drug transporter expression and function at the blood-brain barrier.” Expert opinion on drug metabolism & toxicology 10.10 (2014): 1403-1417. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282594/